TransMedics Group, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US89377M1099
USD
124.70
1.22 (0.99%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
605.49
441.54
241.62
93.46
30.26
25.64
23.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
605.49
441.54
241.62
93.46
30.26
25.64
23.60
Raw Material Cost
242.89
179.66
87.63
28.19
9.10
9.28
9.96
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.78
14.41
10.79
3.73
3.87
3.98
4.35
Selling and Distribution Expenses
184.97
168.42
117.45
69.90
38.28
24.19
23.60
Other Expenses
5.53
4.16
2.53
2.31
1.84
1.46
1.53
Total Expenditure (Excl Depreciation)
496.91
404.04
241.14
124.90
69.69
52.02
53.21
Operating Profit (PBDIT) excl Other Income
108.6
37.5
0.5
-31.400000000000002
-39.4
-26.400000000000002
-29.6
Other Income
12.72
12.69
12.85
-0.43
-0.88
1.65
0.79
Operating Profit (PBDIT)
148.49
69.95
21.61
-27.67
-37.66
-23.15
-27.59
Interest
13.78
14.41
10.79
3.73
3.87
3.98
4.35
Exceptional Items
0.00
0.00
-29.21
-0.57
0.00
0.00
-0.34
Gross Profit (PBDT)
362.61
261.88
153.99
65.27
21.16
16.36
13.64
Depreciation
27.18
19.76
8.28
4.20
2.65
1.58
1.22
Profit Before Tax
107.52
35.78
-26.67
-36.16
-44.18
-28.72
-33.51
Tax
-82.77
0.32
-1.64
0.07
0.04
0.03
0.04
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
190.29
35.46
-25.03
-36.23
-44.22
-28.75
-33.55
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
190.29
35.46
-25.03
-36.23
-44.22
-28.75
-33.55
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
190.29
35.46
-25.03
-36.23
-44.22
-28.75
-33.55
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
473.10
228.60
137.20
187.38
67.85
103.89
54.65
Earnings per share (EPS)
4.87
1.01
-0.77
-1.23
-1.6
-1.16
-2.36
Diluted Earnings per share
4.87
1.01
-0.77
-1.23
-1.6
-1.16
-2.36
Operating Profit Margin (Excl OI)
17.93%
8.49%
0.2%
-33.64%
-130.29%
-102.91%
-125.42%
Gross Profit Margin
22.25%
12.58%
-7.61%
-34.21%
-137.24%
-105.85%
-136.78%
PAT Margin
31.43%
8.03%
-10.36%
-38.77%
-146.11%
-112.13%
-142.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 37.15% vs 82.74% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 436.06% vs 242.00% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 137.00% vs 551.14% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -4.17% vs 33.33% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of TransMedics Group, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
605.49
239.44
366.05
152.88%
Other Operating Income
0.00
0.00
0.00
Total Operating income
605.49
239.44
366.05
152.88%
Raw Material Cost
242.89
62.55
180.34
288.31%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
13.78
0.00
13.78
Selling and Distribution Expenses
184.97
183.56
1.41
0.77%
Other Expenses
5.53
3.93
1.60
40.71%
Total Expenditure (Excl Depreciation)
496.91
285.38
211.53
74.12%
Operating Profit (PBDIT) excl Other Income
108.58
-45.94
154.52
336.35%
Other Income
12.72
9.38
3.34
35.61%
Operating Profit (PBDIT)
148.49
-27.80
176.29
634.14%
Interest
13.78
0.00
13.78
Exceptional Items
0.00
-45.77
45.77
100.00%
Gross Profit (PBDT)
362.61
176.90
185.71
104.98%
Depreciation
27.18
8.69
18.49
212.77%
Profit Before Tax
107.52
-82.26
189.78
230.71%
Tax
-82.77
-1.81
-80.96
-4,472.93%
Provisions and contingencies
0
0
0.00
Profit After Tax
190.29
-80.45
270.74
336.53%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
190.29
-80.45
270.74
336.53%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
190.29
-80.45
270.74
336.53%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
473.10
344.18
128.92
37.46%
Earnings per share (EPS)
4.87
-1.62
6.49
400.62%
Diluted Earnings per share
4.87
-1.62
6.49
400.62%
Operating Profit Margin (Excl OI)
17.93%
-19.16%
0.00
37.09%
Gross Profit Margin
22.25%
-30.73%
0.00
52.98%
PAT Margin
31.43%
-33.60%
0.00
65.03%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 60.55 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 37.15% vs 82.74% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 19.03 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 436.06% vs 242.00% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.58 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 137.00% vs 551.14% in Dec 2024

Annual - Interest
Interest 1.38 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -4.17% vs 33.33% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.93%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024